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Eukaryotic genomes are packaged with histones and accessory proteins in the form of chromatin. RNA
polymerases and their accessory proteins are sufficient for transcription of naked DNA, but not of
chromatin, templates in vitro. In this study, we purified and identified nucleolin as a protein that allows
RNA polymerase II to transcribe nucleosomal templates in vitro. As immunofluorescence confirmed that
nucleolin localizes primarily to nucleoli with RNA polymerase I, we demonstrated that nucleolin allows
RNA polymerase I transcription of chromatin templates in vitro. The results of chromatin immunopre-
cipitation experiments established that nucleolin is associated with chromatin containing rRNA genes
transcribed by RNA polymerase I but not with genes transcribed by RNA polymerase II or III. Knockdown
of nucleolin by RNA interference resulted in specific inhibition of RNA polymerase I transcription. We
therefore propose that an important function of nucleolin is to permit RNA polymerase I to transcribe
nucleolar chromatin.
Eukaryotic cells contain three nuclear enzymes that tran-
scribe DNA, RNA polymerases I, II, and III, which are re-
sponsible for transcription of rRNA genes, all protein coding
genes, and genes encoding various small RNAs, respectively.
Although these are large, multisubunit enzymes, none alone is
capable of specific initiation of transcription. Rather, initiation
from their cognate promoters requires the participation of
polymerase-dedicated initiation proteins such as UBF and SL1
in the case of RNA polymerase I and the six general transcrip-
tion factors (GTFs) for RNA polymerase II (see references 25,
56, 60, 67, 70, and 75 for reviews). The biochemical studies that
led to the identification of the RNA polymerases and these
accessory proteins focused on initiation and used naked tem-
plates. However, in eukaryotes, genomic DNA is packaged
with histones and non-histone-associated proteins in the form
of chromatin. Consequently, RNA polymerases must negotiate
chromatin during transcription in vivo.
The basic repeating unit of chromatin, the nucleosome, com-
prises 147 bp of DNA wrapped around a histone octamer
consisting of two copies of the core histones H2A, H2B, H3,
and H4 (46). The majority of nucleosomes in mammalian cells
are periodically spaced, with an average repeat length of 190
bp (54). In the presence of linker histones such as histone H1,
nucleosomal arrays form the more compact 30-nm fiber, in
which nucleosomes are stacked in a helical arrangement (87).
The 30-nm chromatin fiber can be further condensed to form
higher-order structures, a property that allows the storage of
large DNA genomes in an organized manner. However, such
condensation reduces the access of transcription machines to
DNA templates. Consequently, actively transcribed genes are
generally associated with less-condensed chromatin that is de-
void of linker histones and contains histones carrying specific
modifications (65, 81).
Regions of transcriptionally active chromatin are enriched in
histones that are posttranslationally modified by the covalent
addition of acetyl groups to specific lysine residues (27, 28).
Several histone acetyltransferases, such as GCN5, PCAF, and
Tip60, have been found to be components of multiprotein
transcriptional activators (62). Conversely, histone deacety-
lases, which remove acetyl groups from histones, have been
shown to participate in the repression of transcription and
several have been identified as subunits of transcriptional core-
pressors (29, 39, 52, 90, 91). Another common histone modi-
fication that regulates access to chromatin templates is lysine
methylation (37, 38, 80). Depending on the specific lysine res-
idues that are methylated, this modification can either repress
or activate transcription (49). ATP-dependent chromatin re-
modeling enzymes form another class of proteins that manip-
ulate the structure of chromatin. The first to be identified, the
SWI/SNF complex of Saccharomyces cerevisiae, has been di-
rectly implicated in the transcription of some genes (11, 17, 32,
36). Biochemical studies have established that members of the
SWI/SNF family use ATP hydrolysis to alter the conformation
of histones within a nucleosome (32, 36, 42, 74). Members of
the ISWI family, which all possess a homolog of the Drosophila
ISWI protein, have been identified in many organisms and use
energy from ATP hydrolysis to slide nucleosomes translation-
ally along DNA (33, 40, 41, 63, 84).
In vitro, RNA polymerase II requires only the GTFs to
initiate and elongate transcription from a naked DNA tem-
plate. However, these components are incapable of transcrib-
ing a DNA template that has been assembled into chromatin
(59). This observation led to the discovery of the heterodimeric
protein FACT (facilitates chromatin transcription), which per-
mits RNA polymerase II to elongate transcription through
nucleosomes (57). FACT is composed of a human homologue
of S. cerevisiae protein Spt16 and HMG1-like protein SSRP1.
Biochemical studies have demonstrated that FACT interacts
specifically with histones H2A and H2B (4, 58). The Spt16
subunit possesses histone chaperone activity that is thought to
destabilize the nucleosome and allow transient displacement of
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H2A and H2B during RNA polymerase II elongation (4). It
has not yet been firmly established whether FACT is the only
mammalian protein that allows chromatin transcription by
RNA polymerase II or whether FACT functions with the other
RNA polymerases. To address such issues, we set out to iden-
tify additional proteins that stimulate transcription through
nucleosomes in the presence of limiting concentrations of
FACT. Here we report the purification and identification one
such protein, nucleolin, which we demonstrate is essential for
RNA polymerase I transcription in vivo.
MATERIALS AND METHODS
Purification of proteins required for RNA polymerase II transcription and
chromatin assembly. The purification of RNA polymerase II and transcription
factor IIH (TFIIH) from mammalian cell nuclear extract and of TATA-binding
protein (TBP), TFIIB, TFIIE, and TFIIF synthesized in Escherichia coli was
done as described previously (47). Core histones, RSF, and FACT were purified
from HeLa cell nuclei by following previously described protocols (40, 57, 79). A
chimeric activator (GAL4-AD) composed of a FLAG-tagged GAL4 DNA-bind-
ing domain fused to the activation domain of c-Myc was synthesized in Hi-5
insect cells and purified by immunoaffinity chromatography as described previ-
ously (50).
In vitro chromatin assembly. RSF-mediated chromatin assembly was per-
formed essentially as described previously (44, 45), typically by using 4 g of
template DNA and empirically optimized ratios of core histones to DNA. As-
sembly was monitored by limited digestion with micrococcal nuclease (Sigma),
and the DNA products were purified and examined by agarose gel electrophore-
sis (44). Chromatin assembled in this way was typically frozen at 80°C until use.
In vitro transcription by RNA polymerase II. The pG5MLP plasmid contains
five binding sites for the yeast GAL4 protein fused to the adenovirus major late
promoter and a G-less cassette (71). Transcription reaction mixtures were pre-
pared as described previously (15, 57) and contained 200 ng of pG5MLP naked
or assembled into chromatin as indicated, 10 ng of TBP, 10 ng of TFIIB, 10 ng
of TFIIF, 50 ng of TFIIE, 150 ng of TFIIH, and 100 ng of RNA polymerase II.
For transcription of chromatin templates, reaction mixtures also contained var-
ious concentrations of FACT, as indicated (0.25 is 375 ng, 0.5 is 750 ng, 1
is 1.5 g, 2 is 3 g, and 3 is 4.5 g of FACT, respectively). Reaction mixtures
containing nucleolin contained 1.2 g of purified protein. Following incubation
at 30°C for 1 h, transcription products were digested with 50 U of RNase T1
(Roche) for 30 min at 30°C. The RNA was then purified and analyzed by
electrophoresis in 6% polyacrylamide gels containing 8 M urea, cast, and run in
0.09 M Tris-borate, pH 7.5, containing 2 mM EDTA (1 TBE). The gels were
dried and subjected to autoradiography at 80°C with intensifying screens.
Immunoblotting. Proteins were resolved by sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis (PAGE) and transferred to Immobilon (Mil-
lipore Incorporated). The membranes were blocked by incubation in 20 mM
Tris-HCl, pH 7.5, containing 0.2 M NaCl, 0.5% (vol/vol) Tween 20 (TBST), and
10% (wt/vol) nonfat milk for 1 h at 25°C. Antibodies used in this study were
anti-FLAG M2 (Sigma), anti-hSpt16 (Transduction Laboratories), antinucleolin
(Stressgen), anti--actin (Abcam), and anti-mouse secondary antibodies conju-
gated to horseradish peroxidase (Promega). Antibody incubations were per-
formed with TBST containing 1% (wt/vol) milk, and the blots were developed by
enhanced chemiluminescence (Amersham Biosciences).
Nucleolin purification. Human nuclear extract (800 mg of protein) was pre-
pared from HeLa cells grown in suspension culture as described previously (12).
The extract was dialyzed into 20 mM Tris-HCl, pH 7.9, containing 0.2 mM
EDTA, 10 mM -mercaptoethanol, 0.2 mM phenylmethylsulfonyl fluoride
(PMSF), 20% (vol/vol) glycerol (BC buffer), and 50 mM KCl (BC50). The extract
was applied to a DEAE-cellulose column (DE52; Whatman), and bound proteins
were eluted with BC500, dialyzed into BC100, and loaded onto a phosphocellu-
lose column (P11; Whatman). The P11 column was eluted sequentially with BC
buffer containing 0.35, 0.65, and 1.0 M KCl. The flowthrough fraction was
dialyzed into BC50 and loaded onto an SP-Sepharose column (Pharmacia). This
column was eluted sequentially with BC buffer containing 0.1, 0.2, 0.3, 0.5, and
1 M KCl. The peak activity was detected in the 0.2 M eluate, which was dialyzed,
loaded onto a DEAE-5PW column (TosoHaas), and eluted with a linear gradient
of 50 mM KCl to 0.7 M (NH4)2SO4 in BC buffer. The chromatin-specific stim-
ulatory activity eluted at 300 mM (NH4)2SO4. The active fractions were pooled
and adjusted to 60% saturation with (NH4)2SO4. The soluble fraction was dia-
lyzed into BC50, and the proteins were concentrated by chromatography on a
DE52 column. They were then fractionated on a Superdex 200 (Pharmacia) gel
filtration column run in BC100. The active fractions eluted with an apparent
molecular mass of 125 kDa. The stimulatory activity present in the 0.35 M KCl
P11 fraction was dialyzed into BC50 and subjected to chromatography on SP-
Sepharose and DEAE-5PW columns exactly as described above. The active
fractions from the DEAE-5PW column [eluting at 0.3 M (NH4)2SO4] were
pooled and subjected to gel filtration with a Superose 6 column (Pharmacia). The
activity eluted with an apparent molecular mass of 125 kDa. The 125-kDa
proteins from both purifications were excised from SDS-polyacrylamide gels and
subjected to mass spectrometry by ProtTech Incorporated.
Nucleolin immunodepletion. The antinucleolin antibody described previously
or the B6 monoclonal antibody against an adenoviral protein (64) was bound to
protein A/G beads (Santa Cruz Biotechnology, Inc.) that had been preblocked by
incubation with 1 g/ml bovine serum albumen by rotation at 4°C overnight. The
antibody-coupled beads, as well as preblocked beads alone, were washed with
phosphate-buffered saline, added to purified nucleolin that had been dialyzed
into BC100 without -mercaptoethanol, and rotated at 4°C for 2 h. The super-
natants from the immunodepletions were collected and assayed for transcrip-
tional activity and by immunoblotting as described above.
Production of FLAG-nucleolin. Nucleolin cDNA (26), a kind gift of Les Hana-
kahi, Johns Hopkins University, was subcloned into a CF expression vector that
includes the cytomegalovirus promoter and an amino-terminal FLAG tag (53).
This vector was introduced into 293 cells by the calcium phosphate precipitation
method, and nuclei were prepared 24 h later by hypotonic lysis in 10 mM
Tris-HCl, pH 7.8, containing 1.5 mM MgCl2, 0.25 M sucrose, and 0.5 mM PMSF
(10). Nuclei were collected by centrifugation at 3,000 rpm and lysed by Dounce
homogenization in BC buffer containing 0.5 M NaCl without -mercaptoethanol.
The extract was cleared by centrifugation at 13,000 rpm for 15 min and applied
to anti-FLAG M2 resin (Sigma) overnight at 4°C with rotation. The beads were
washed with the same buffer, and proteins were eluted by competition with
FLAG peptide in BC buffer containing 50 mM NaCl without -mercaptoethanol
for 12 h at 4°C. The eluted proteins were analyzed by SDS-PAGE and stored at
80°C.
Immunofluorescence. HeLa cells were grown on glass slides, fixed, and probed
as described previously (23, 55). Nucleolin, RNA polymerase I (RPA194 sub-
unit), TFIIF (RAP 30 subunit), and RNA polymerase II were detected with
rabbit polyclonal antibodies (Santa Cruz Biotechnology, Inc.) and Cy5-conju-
gated goat anti-rabbit secondary antibody (Jackson ImmunoResearch Labora-
tories, Inc.). The DNA was stained with 4,6-diamidino-2-phenylindole (DAPI)
by the standard protocol. Stained cells were examined by confocal microscopy
with a Zeiss LSM 510 confocal microscope with a 40 water immersion C-
Apochromat objective.
In vitro RNA polymerase I transcription assays. RNA polymerase I and SL-1
were purified from HeLa cell nuclear extracts by combining previously described
protocols (16, 51, 66). For RNA polymerase I, HeLa cell nuclear extracts were
prepared as described previously (8) and fractionated over DEAE-5PW (Toso-
Haas), CM-Sepharose (Pharmacia), heparin-Sepharose HiTrap (Pharmacia),
and Superose 6 (Pharmacia). Purification of RNA polymerase I was followed by
immunoblotting for RPA194, the largest subunit, with a rabbit polyclonal anti-
body (Santa Cruz) and by nonspecific transcription (66). SL-1 was purified from
HeLa cell nuclear extract by chromatography on DEAE-cellulose (Whatman),
heparin-agarose (Sigma), SP-Sepharose, and Superdex 200. Its purification was
monitored by immunoblotting for TBP with an anti-TBP monoclonal antibody
(9). The FLAG-UBF1 expression plasmid was a kind gift from Ingrid Grummt
and Renate Voit. FLAG-UBF1 protein was synthesized in 293 cells and purified
by immunoaffinity chromatography.
The template for transcription was the plasmid pHrP2, which contains the
human rRNA gene from positions 411 to 375. Transcription reaction mix-
tures contained 200 ng of pHrP2, either naked or nucleosome assembled by RSF;
150 ng of purified RNA polymerase I; 30 ng of SL-1; 20 ng of FLAG-UBF-1; 3
mM each ATP, CTP, UTP, and GTP; 12 U of RNasin (Promega); 10 mM
HEPES-KOH, pH 7.9; 50 mM KCl; 6 mM MgCl2; 1.25% (wt/vol) PEG 8000; and
FACT (1.5 g) or nucleolin (1.2 g) as indicated. Reaction mixtures were
incubated for 1 h at 30°C and treated with 20 U of RNase-free DNase I (Roche
Diagnostics) for 1 h at 37°C, and reactions were stopped with 20 mM EDTA, pH
7.5, containing 0.2 M NaCl, 1% SDS (wt/vol), and 25 g of glycogen. The RNA
was deproteinized by sequential extractions with phenol and Trizol (Invitrogen),
precipitated with 2-propanol, washed with 70% ethanol, and resuspended in 20
l of H2O. The RNA transcripts (1 l) were amplified and labeled by One-Step
reverse transcription (RT)-PCR (Roche Diagnostics) (16 cycles) in reaction
mixtures containing [-32P]dATP at 3 Ci/reaction mixture (3,000 Ci/mmol;
Perkin-Elmer) by following the manufacturer’s procedures. The 5 primer cor-
responded to positions 1 to 22 of the rRNA gene (GCTGACACGCTGTC
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CTCTGGCG), and the 3 primer was complementary to positions 251 to 270
(CGCCCCGGGCGCCCGCAGCG). The PCR products (one-fifth of the final
reaction mixture) were separated by electrophoresis in 6% polyacrylamide gels
cast and run in 0.25 TBE and visualized by autoradiography.
Immunoprecipitation of nucleolin-associated histones. Nuclei were purified
from 293 cells synthesizing nucleolin carrying an N-terminal FLAG tag as de-
scribed in a previous section. They were then resuspended in 10 mM Tris-HCl,
pH 7.5, containing 10 mM NaCl, 3 mM MgCl2, 3 mM CaCl2, and 0.1 mM PMSF,
and chromatin was released from the nuclei by limited digestion with micrococcal
nuclease (Sigma) at 37°C for 10 min (83). The digestion was stopped by addition
of EDTA to 25 mM. Debris was removed by centrifugation, and the soluble
chromatin was subjected to immunoprecipitation with M2 FLAG beads (Sigma)
as described above. The eluted proteins were resolved by electrophoresis in 17%
polyacrylamide gels containing 1% (wt/vol) SDS and visualized by Coomassie
blue staining. Nucleophosmin, another nucleolar protein, was identified by mass
spectrometry as described in a previous section.
Chromatin immunoprecipitation. Proteins were cross-linked to the DNA in
HeLa cells in situ by the addition of formaldehyde to 1% (vol/vol) to the culture
medium, with gentle rocking for 10 min at 25°C. Glycine was added to 0.125 M,
and the cells were rocked for 5 min to stop the reaction. Cells were then washed
with phosphate-buffered saline, and the nuclei were isolated by NP-40 extraction
as described previously (22, 31). Nuclei were resuspended and subjected to
limiting micrococcal nuclease digestion as described above. Six packed cell vol-
umes of 10 mM Tris-HCl, pH 7.05, containing 50 mM NaCl, 30 mM Na4P2O7, 50
mM NaF, 5 M ZnCl2, 10% (vol/vol) glycerol, 0.1 mM PMSF, and 0.1% (vol/vol)
Triton X-100 were added to ensure release of DNA. Following sonication for
20 s to produce DNA fragments of 500 to 2,000 bp, the insoluble debris was
removed by centrifugation. The lysates were precleared by rotation with protein
A/G beads that had been blocked by incubation with 1 g/ml bovine serum
albumin and 1 g/ml sonicated salmon sperm DNA at 4°C overnight. The
cross-linked DNA was immunoprecipitated by addition of 2 g of antinucleolin
monoclonal antibody (Stressgen) and preblocked protein A/G beads or pre-
blocked protein A/G beads alone. Cross-links were reversed as described previ-
ously (35). The immunoprecipitated DNA was purified by using QIAGEN PCR
purification spin columns and analyzed by limiting PCR in the presence of
[-32P]dATP at 3 Ci/reaction mixture (3,000 Ci/mmol; Perkin-Elmer) with
primer pairs specific for human genes encoding rRNA (positions 948 to 1028
of the 18S rRNA coding sequence), the intergenic rRNA gene (positions 35176
to 35346), geminin (positions 68 to 347), -globin (positions 1460 to
1685), Rpl7 (positions 200 to 440), Rps28 (positions 254 to 440),
tRNASer (positions 12 to 6 bp beyond the end of the gene), and tRNAVal
(positions 9 to 4 bp beyond the end of the gene). Human -actin DNA was
examined with primers for a commercially available amplicon (Applied Biosys-
tems). The number of PCR cycles and the concentration of input DNA were
optimized for exponential amplification. The PCR products were resolved by
electrophoresis in 6% polyacrylamide gels cast and run in 0.25 TBE, and
signals were quantified with Image J software.
Nucleolin RNA interference (RNAi). Nucleolin Stealth RNAi Select (NCL-
HSS106985; Invitrogen) and control Stealth RNAi Negative Control (catalog
no. 12935-200; Invitrogen) were introduced into HeLa cells with TransFectin
(Bio-Rad) by following the manufacturer’s protocols. After 24 h, the medium
was replaced and cells were harvested at 72 h post RNAi introduction. Total
protein was extracted in 10 mM Tris-HCl, pH 7.05, containing 50 mM NaCl,
30 mM Na4P2O7, 50 mM NaF, 5 M ZnCl2, 10% (vol/vol) glycerol, 0.1 mM
PMSF, and 0.5% (vol/vol) Triton X-100 and analyzed by immunoblotting.
Total RNA was prepared by Trizol (Invitrogen) extraction, precipitated with
2-propanol, washed with 70% ethanol, resuspended, and digested with 20 U
of RNase-free DNase I (Roche Diagnostics) for 1 h at 37°C. RNA was
prepared by phenol extraction, precipitated with 2-propanol, washed with
70% ethanol, and resuspended in distilled H2O. Target RNA was amplified as
described for RNA polymerase I transcription assays. The primers used for
PCR were as described in the RNA polymerase I transcription and chromatin
immunoprecipitation sections.
RESULTS
Analysis of RNA polymerase II transcription from chroma-
tin templates. In order to identify proteins that enhance elon-
gation in a reconstituted RNA polymerase II transcription
system, we used purified chromatin templates. Such templates
allow efficient initiation by RNA polymerase II and GTFs.
However, engaged polymerase molecules stall upon encoun-
tering a nucleosome and hence cannot elongate transcripts.
The DNA template used for assembly contained a 390-bp
G-less cassette under the control of a synthetic promoter con-
taining five GAL4 DNA-binding sites upstream of the basal
adenovirus major late promoter. Chromatin was assembled
onto this DNA by using purified core histones and the ATP-
dependent chromatin assembly factor RSF (43–45). The
GAL4-AD activator protein (described in Materials and Meth-
ods) was included in assembly reaction mixtures to induce the
formation of a nucleosome-free promoter region (44). These
assembly components are shown in Fig. 1A. As anticipated
(43–45), micrococcal nuclease digestion of the chromatin tem-
plate assembled in this way indicated the presence of regularly
spaced nucleosomes (Fig. 1B). As previously reported, RNA
polymerase II and the GTFs (TFIIB, TFIIE, TFIIF, TFIIH,
and TBP) directed efficient transcription of the naked DNA
template (Fig. 1C, left side) but failed to support transcription
through the nucleosome array. As shown in Fig. 1C, such
nucleosome-induced inhibition can be overcome by addition of
FACT to the reaction mixtures.
Identification of proteins that stimulate transcription of
chromatin by RNA polymerase II. We used reaction mixtures
containing a limiting concentration of FACT to identify addi-
tional human proteins that stimulate RNA polymerase II tran-
scription from chromatin templates. The concentration of
FACT used in these assays precluded efficient transcription of
the chromatin template (Fig. 2A, lanes 1 and 2). However, the
addition of the 0.1 and 0.35 M P11 fractions derived from the
second chromatographic step strongly stimulated transcription
of the chromatin template (Fig. 2A, lanes 3 and 4). Immuno-
blotting of the P11 fractions for the human Spt16 protein
confirmed that such stimulation was not mediated by endoge-
nous FACT (Fig. 2A, bottom). This protein was not present in
either the 0.1 M or the 0.35 M phosphocellulose fraction, and
its concentration in the 0.65 M fraction was too low to stimu-
late transcription in this assay. The stimulatory activities
present in both the 0.1 and 0.35 M phosphocellulose fractions
were purified further (Fig. 2B). The 0.1 M fraction was frac-
tionated through five additional chromatographic steps, culmi-
nating in gel filtration on Superdex 200, from which the stim-
ulatory activity eluted in a single peak with an apparent
molecular mass of 125 kDa. Coomassie blue staining of the
fractions separated by SDS-PAGE identified a single protein
of 125 kDa that coeluted with the stimulatory activity (Fig.
2C). The 0.35 M fraction was fractionated through three ad-
ditional chromatographic steps, as summarized in Fig. 2B.
Coomassie blue staining of the fractions from the final chro-
matographic step, a Superose 6 column, revealed a single pro-
tein of 125 kDa that coeluted with the stimulatory activity
(Fig. 2D). The 125-kDa proteins recovered from both the
Superdex 200 and Superose 6 columns were identified by mass
spectrometry as nucleolin, an abundant nucleolar protein that
participates in ribosome biogenesis. We have not investigated
the basis of the initial separation of nucleolin into two phos-
phocellulose fractions. However, nucleolin is subject to cell
cycle-dependent phosphorylation at multiple sites, as well as to
methylation and ADP ribosylation (78). It is therefore possible
that the nucleolin recovered from the 0.1 and 0.35 M P11
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fractions differed with respect to one or more of these modi-
fications.
Nucleolin possesses FACT-like activity. In order to confirm
that the stimulation of chromatin transcription was due to
nucleolin and not some minor component(s) in the frac-
tions, we performed immunodepletion experiments. The
peak activity fractions from the Superdex 200 column were
depleted with a monoclonal antibody against nucleolin cou-
pled to protein A/G beads, with a control monoclonal anti-
body against an adenoviral protein coupled in the same
fashion, or with A/G beads alone. The ability of purified
nucleolin to stimulate transcription was inhibited only by the
antinucleolin antibody (Fig. 3A, lane 5): neither beads alone
nor the control antibody inhibited transcription (Fig. 3A,
lanes 3 and 4) or decreased the concentration of nucleolin
(Fig. 3B).
We next tested the activity of highly purified, FLAG-tagged
nucleolin (Fig. 4). Nucleolin purified in this way also stimu-
lated chromatin transcription (Fig. 4B, lane 4). Furthermore, it
supported efficient chromatin transcription in the absence of
FACT (Fig. 4B, lane 5), as did highly purified native nucleolin
(data not shown). Moreover, nucleolin was as effective as a
FIG. 1. FACT-dependent RNA polymerase II transcription of a chromatin template. (A) In vitro chromatin assembly. The proteins used for
chromatin assembly are shown after electrophoresis in polyacrylamide gels containing SDS and Coomassie blue staining. (B) Chromatin assembled
onto the pG5MLP plasmid was digested with two concentrations of micrococcal nuclease (MNase), resolved by electrophoresis in a 1.3% agarose
gel, and visualized by ethidium bromide staining. The arrow indicates an increasing concentration of micrococcal nuclease. (C) Transcription
reaction mixtures contained naked (left side) or chromatin-assembled (middle) pG5MLP and the transcriptional components and concentrations
of FACT indicated. RNA labeled in vitro was purified and visualized as described in Materials and Methods. The right side shows purified FACT
analyzed by SDS-PAGE and Coomassie blue staining. Ad MLP, adenovirus major late promoter.
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saturating concentration of FACT (compare lanes 2 and 5, Fig.
4B). Importantly, nucleolin, like FACT, is chromatin specific
because it failed to stimulate transcription from the naked
DNA template (Fig. 4C).
Nucleolin and RNA polymerase I localize to nucleoli. To
determine whether nucleolin exists outside nucleoli, where it
might affect transcription by RNA polymerase II, we examined
its subcellular distribution by immunofluorescence. In agree-
FIG. 2. Purification of proteins that stimulate transcription of chromatin templates by RNA polymerase II. (A) Transcription reaction mixtures
contained the chromatin template described in the legend to Fig. 1B, the quantities of FACT indicated at the top, and equal volumes of the P11 fractions
indicated. The bottom part shows the immunoblotting of these fractions for the hSpt16 subunit of FACT. (B) Summary of purification of stimulatory
activities from the 0.1 and 0.35 M P11 fractions. NE, nuclear extract; ppt., precipitation. Panels C and D show the results of the final steps in purification
of the activities detected in the 0.1 and 0.35 M P11 fractions. In each case, the top and bottom parts show the results of assaying the fractions indicated
under the conditions described for panel A and of analysis of the proteins present in the fractions by SDS-PAGE and Coomassie blue staining,
respectively. The proteins marked by the arrows were identified as nucleolin by mass spectroscopy. nt, nucleotides; M, markers.
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ment with previous studies (26, 73), we found that nucleolin is
present primarily in the nucleoli (Fig. 5A). Also in agreement
with previous reports, RNA polymerase I localized to nucleoli,
the sites of rRNA gene transcription (Fig. 5B) (72). In con-
trast, TFIIF and RNA polymerase II were observed through-
out the nucleus but were excluded from nucleoli (Fig. 5C and
D). These results suggest that in vivo nucleolin most likely
participates in RNA polymerase I transcription. However, as
nucleolin is an abundant protein (5, 21), we cannot exclude the
possibility that a small percentage is present at extranucleolar
sites.
Nucleolin facilitates transcription of chromatin by RNA
polymerase I. To asses the role of nucleolin in transcription by
RNA polymerase I, we used an RNA polymerase I transcrip-
tion system composed of highly purified components (Fig. 6A).
Transcription was monitored by RT-PCR with primers corre-
sponding to positions 1 to 270 of the human rRNA gene. In
conjunction with the TBP-containing protein SL-1, RNA poly-
merase I initiated transcription from the rRNA gene promoter
in a naked DNA template (Fig. 6B, lane 3). Such transcription
was further enhanced by the site-specific upstream binding
factor UBF (Fig. 6B, lane 4) (16). However, nucleolin did not
stimulate transcription from this naked DNA template (Fig.
6C). To investigate whether nucleolin could allow RNA poly-
merase I to elongate transcription on a nucleosomal template,
the plasmid containing the rRNA gene promoter was assem-
bled into chromatin as described in a previous section. The
reconstituted RNA polymerase I transcription system failed to
transcribe the chromatin template (Fig. 6D, lane 1). However,
in the presence of nucleolin (or FACT), robust transcription
was observed (Fig. 6D, lanes 2 and 3).
Nucleolin is associated with chromatin containing the rRNA
gene. To determine whether nucleolin associates with chroma-
tin, we performed chromatin immunoprecipitation experi-
ments. Nuclei were isolated from 293 cells synthesizing FLAG-
nucleolin by hypotonic lysis and treated with micrococcal
nuclease to release chromatin fragments ranging in size from 1
to 20 nucleosomes. The chromatin was immunoprecipitated
with FLAG-antibody-beads, which were then washed and
eluted by competition with FLAG peptide. The proteins
present in the various fractions were separated by SDS-PAGE
and visualized by staining with Coomassie blue. FLAG-nucleo-
lin was found to be associated with all four core histones, as
well as with nucleophosmin, another abundant nucleolar pro-
tein (Fig. 7A, lane 4). The observation that nucleolin can
associate with both core histones and nucleophosmin sug-
gested that endogenous nucleolin might be bound to nucleolar
chromatin formed on rRNA genes.
To test this hypothesis, we performed a conventional chro-
matin immunoprecipitation experiment with a monoclonal an-
tibody that recognizes native nucleolin. HeLa cell chromatin
was cross-linked in situ with formaldehyde, released, and im-
munoprecipitated with this antibody or protein with A/G beads
alone, as described in Materials and Methods. The immuno-
precipitated DNA was purified and analyzed by limiting PCR
with primers for human genes transcribed by RNA poly-
merases I, II, and III. The rRNA gene that is actively tran-
scribed was significantly enriched in the chromatin immuno-
precipitated by the antinucleolin antibody compared to that
precipitated by beads alone (Fig. 7B). Quantification of four
independent experiments indicated that the enrichment of the
rRNA gene was approximately 11-fold (Fig. 7B). In these ex-
periments, nucleolin immunoprecipitation of chromatin did
not result in significant enrichment of several genes transcribed
by RNA polymerase II, including those encoding ribosomal
proteins Rpl7 and Rps28, or of two tRNA genes transcribed by
RNA polymerase III (Fig. 7B).
Nucleolin is essential for RNA polymerase I transcription.
To investigate the role of nucleolin in transcription by RNA
polymerase I in vivo, we used short interfering RNAs (siR-
NAs), which induce the degradation of mRNAs to which
they are targeted (RNAi) (14). Introduction of an siRNA
specific for nucleolin resulted in a decrease in the concen-
tration of this protein, but not of -actin, whereas a control
siRNA had no effect (Fig. 8A). We therefore examined the
concentration of 45S pre-rRNA in HeLa cells exposed to
these siRNAs by RT-PCR. The reduction in the concentra-
tion of nucleolin induced by RNAi was accompanied by a
decrease in the transcription of rRNA genes mediated by
RNA polymerase I but not in transcription by RNA poly-
merase II (Fig. 8B). Furthermore, in several independent
experiments, the extent of inhibition of RNA polymerase I
transcription correlated with the degree to which nucleolin
was knocked down (data not shown). These results indicate
that nucleolin is required for transcription of rRNA genes
by RNA polymerase I in vivo.
FIG. 3. Nucleolin is the protein responsible for chromatin tran-
scription activity. (A) Chromatin templates were transcribed in the
presence of a limiting concentration (0.5) of FACT (all lanes) and
purified nucleolin (lane 2) or purified nucleolin that had been mock
depleted with beads alone (M) (lane 3) or incubated with control
antibody bound to beads (C) (lane 4) or with antinucleolin antibody
bound to beads (Nuc) (lane 5). nt, nucleotides. (B) Immunoblotting
of these same nucleolin preparations with an antinucleolin anti-
body.
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DISCUSSION
Nucleolin is an abundant, conserved, RNA-binding protein
that resides primarily in eukaryotic cell nucleoli. Numerous
correlative studies have implicated this protein in various as-
pects of ribosome biogenesis, including pre-rRNA processing,
assembly of ribosomal subunits, and movement of ribosomes
or their components between the nuclear and cytoplasmic
compartments of eukaryotic cells (21, 85). Nevertheless, few
molecular functions have been unequivocally ascribed to
nucleolin. Here we demonstrate for the first time that nucleo-
lin is required for transcription of rRNA genes by RNA poly-
merase I in vivo: knockdown of nucleolin by RNAi specifically
blocked synthesis of pre-rRNA in HeLa cells (Fig. 8B). Fur-
thermore, the results of chromatin immunoprecipitation ex-
periments established that nucleolin is associated in vivo with
chromatin containing rRNA genes but not with any of several
genes transcribed by RNA polymerase II or III (Fig. 7B).
The conclusion that nucleolin is necessary for efficient tran-
scription of rRNA genes in vivo appears to contradict previous
reports that this protein represses transcription by RNA poly-
merase I in hamster cells and Xenopus oocytes (6, 68). How-
ever, in both cases this function was ascribed to nucleolin on
the basis of the effects of overproduction of the protein, as a
result of either inhibition of proteolytic processing (6) or mi-
croinjection of highly purified, exogenous nucleolin (68). As it
is clear from the results of siRNA-mediated knockdown that
nucleolin is necessary for maximal rRNA gene transcription in
vivo (Fig. 8), it is likely that these higher-than-physiological
concentrations of nucleolin inhibited transcription indirectly.
High concentrations of this protein could, for example, seques-
ter components that are required for transcription by RNA
polymerase I, such as UBF, with which fluorescently labeled,
exogenous nucleolin colocalizes (68). As phosphorylation of
nucleolin serine residues correlates with active transcription of
the rRNA gene (see below), it is also possible that abnormally
FIG. 4. Nucleolin specifically stimulates transcription of a chromatin template. (A) Coomassie blue staining of SDS-PAGE of purified
FLAG-tagged nucleolin. (B) FLAG-nucleolin was assayed in chromatin transcription assays. (C) The naked DNA template was transcribed in the
presence of FLAG-nucleolin as indicated. nt, nucleotides; M, markers.
FIG. 5. Nucleolin and RNA polymerase I localize to nucleoli.
HeLa cells were fixed and stained (red) with antibodies against nucleo-
lin (A), RNA polymerase I (B), TFIIF (C), or RNA polymerase II (D).
In all cases, DNA was stained with DAPI (blue).
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high nucleolin concentrations inhibited pre-rRNA synthesis by
perturbing the balance among differentially phosphorylated
forms of the protein.
Previous studies have indicated that nucleolin participates in
the earliest reaction in pre-rRNA processing, endonucleolytic
cleavage at a conserved site within the 5 external transcribed
spacer. Binding of nucleolin to a conserved sequence in the
pre-rRNA substrate is required for cleavage at this site in vitro
(19, 20). It has been proposed that the interaction of nucleolin
with pre-RNA initiates assembly of a pre-RNA processing
complex by recruitment of processing components such as U3
small nucleolar ribonucleoprotein (19). The association of
nucleolin with nascent pre-rRNA in vivo (30) is consistent with
this model. It therefore seems likely that nucleolin coordinates
transcription of rRNA genes by RNA polymerase I with pre-
rRNA processing and in this respect resembles proteins that
both facilitate elongation by RNA polymerase II and partici-
pate in subsequent reactions in mRNA biogenesis (see refer-
ences 34, 48, 69, and 77 for reviews).
Like RNA polymerase II, RNA polymerase I is incapable of
transcribing DNA packaged by nucleosomes in the presence of
its initiation proteins in vitro (Fig. 6) (25). The robust tran-
scription observed upon the addition of nucleolin to such re-
action mixtures (Fig. 6) indicates that nucleolin facilitates elon-
gation by RNA polymerase I during the transcription of
chromatin templates. Whether it also facilitates initiation by
this enzyme has not yet been examined. In the reconstituted
transcription systems used in these studies, nucleolin and
FACT both efficiently stimulated chromatin transcription by
RNA polymerases I and II (Fig. 3, 4, and 6). Such reciprocity
is consistent with our current understanding of the biochemical
properties of these proteins. FACT, which interacts specifically
with histones H2A and H2B (4, 58), has been reported to act
as a histone chaperone and is believed to destabilize the his-
tone octamer (1, 4). Similarly, nucleolin has been shown to
stimulate remodeling and mobilization of nucleosomes by Swi/
Snf and Acf and, alone, to induce transfer of H2A-H2B dimers
to H3-H4 tetramers (1). As the N-terminal 300 amino acids of
nucleolin comprise an H1-like domain (13), it is probable that
nucleolin also binds directly to nucleosomal histones. Indeed,
the N-terminal domain has been reported to decondense chro-
matin in vitro (13), and nucleolin associates with core histones
in vivo (Fig. 7A).
It is well established that the chromatin in which vertebrate
rRNA genes reside regulates rRNA gene transcription and
that entire arrays, or individual genes within rRNA gene re-
peats, can be repressed by deacetylation and methylation of
histones (25). How such inhibitory histone modifications are
FIG. 6. Nucleolin facilitates RNA polymerase (pol) I transcription of
chromatin templates. (A) Coomassie blue staining of SDS-polyacrylamide
gels containing the purified proteins used to reconstitute RNA polymer-
ase I transcription. (B) RNA polymerase I, SL-1, and UBF-1 were added
to transcription reaction mixtures containing an rRNA gene template as
indicated at the top of the panel. The transcripts were amplified by
one-step RT-PCR as described in Materials and Methods. No products
were observed in reaction mixtures that lacked SL1 (lane 2) or con-
tained only nucleolin (data not shown), establishing the specificity for
rRNA transcripts and the absence of rRNA bound to nucleolin, re-
spectively. (C) Nucleolin does not stimulate RNA polymerase I tran-
scription from a naked template. Proteins were added as indicated at
the top of the panel. All reaction mixtures contained RNA polymerase
I, SL-1, and UBF-1. (D) Transcription reaction mixtures contained the
components shown in panel A, the rRNA gene template assembled
into chromatin and FLAG-nucleolin, or FACT, as indicated at the top.
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reversed when transcription is activated and the definitive fea-
tures of chromatin associated with actively transcribed rRNA
genes are not understood. However, it is reasonable to suppose
that nucleolin might mark nucleolar chromatin that is being
transcribed or that can be transcribed. This hypothesis is con-
sistent with our observation that the association of nucleolin
with chromatin containing the rRNA gene showed no de-
crease when HeLa cells were subjected to heat shock at 42°C
for 2 h (data not shown), a stress that inhibits transcription
of RNA genes by some 95% (18). Interestingly, nucleophos-
min, which is also associated with the rRNA gene, has been
shown to stimulate transcription preferentially from a chro-
matin template containing acetylated histones (82). As nu-
cleophosmin does not possess FACT-like activity (58), a
reasonable hypothesis is that the histone chaperone activity
of nucleolin and the binding of nucleophosmin to acetylated
histones function in concert to permit transcription of active
rRNA genes in vivo.
Nucleolin is subject to various posttranslational modifica-
tions, notably cell cycle-dependent phosphorylation of specific
FIG. 7. Nucleolin binds to chromatin containing rRNA. (A) The
association of FLAG-nucleolin with chromosomal histones was exam-
ined by immunoprecipitation. The protein present in input chromatin
(I) and the flowthrough (FT) and peptide-eluted (E) fractions was
examined by SDS-PAGE and Coomassie blue staining. Nucleophos-
phin (fraction E) was identified by mass spectrometry. M, markers (the
values on the left are sizes in kilodaltons). (B) Chromatin immuno-
precipitations of cross-linked HeLa cell chromatin were performed
with control beads (lanes 1) or with 2 g of nucleolin antibody conju-
gated to beads (lanes 2). DNA isolated from the immunoprecipitates
was analyzed by PCR for the genes indicated. Signals were quantified
with Image J software and used to calculate the DNA concentration in
the nucleolin immunoprecipitate relative to that of the control. The
values shown are the means of four independent experiments. mAb,
monoclonal antibody.
FIG. 8. Nucleolin is required for RNA polymerase I transcription.
(A) Immunoblotting of proteins isolated from cells treated with siRNA
for nucleolin, as indicated. (B) RNA isolated from cells treated with
siRNA for nucleolin, as indicated, was amplified by one-step RT-PCR
as described in Materials and Methods.
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residues (78). During interphase, numerous serines, many of
which are located in the N-terminal H1-like domain, are phos-
phorylated by casein kinase II, whereas during mitosis threo-
nine residues in the same domain are modified by Cdc2 (3, 7,
61). Serine phosphorylation correlates with active transcription
of rRNA genes. When cells become contact inhibited, tran-
scription of these genes is reduced by 95%, casein kinase II
leaves nucleoli, and serine phosphorylation is lost. Further-
more, during mitosis, when pre-rRNA is not made (86), the
N-terminal domain is heavily phosphorylated by Cdc2 (3,
61). It is therefore important to determine whether these or
other modifications of nucleolin regulate its ability to asso-
ciate with chromatin and allow transcription by RNA poly-
merase I.
The effect of nucleolin on transcriptional elongation by
RNA polymerase II was also examined in a recent study using
elongation complexes stalled on a mononucleosomal template
(1). In this system, nucleolin induced a modest (1.3-fold) in-
crease in transcription through the nucleosome to the end of
the template (1). Our observation that, in a fully defined tran-
scription system, nucleolin stimulated transcription of chroma-
tin templates by at least a factor of 10 (Fig. 4 and 5) provides
compelling support for the conclusion that this protein can
stimulate transcription by RNA polymerase II. Furthermore,
these data establish that nucleolin is not only necessary but
also sufficient to allow such transcription. Whether it functions
in the same way in vivo is less clear, as is the contribution of
FACT to transcription by RNA polymerase I. The lack of
specificity exhibited by these proteins in vitro can be attributed,
at least in part, to their similar biochemical properties. How-
ever, the highly simplified nature of the chromatin template
used in these experiments is likely to be of even greater im-
portance. These templates were built with nucleosomal his-
tones (Fig. 1A) and consequently lacked both non-histone pro-
tein components and the higher-order structure characteristic
of native chromatin. Furthermore, no in vitro system can re-
produce the spatial and functional compartmentalization of
chromatin within the nucleus. Consequently, we believe that
the reciprocity exhibited by nucleolin and FACT in vitro does
not reflect the physiological functions of these proteins and
propose that the primary role of nucleolin in vivo is to permit
chromatin transcription by RNA polymerase I. This view is
consistent with our observations that nucleolin was associated
with chromatin containing the rRNA gene in HeLa cells but
not with any of several genes transcribed by RNA polymerases
II and III (Fig. 7B) and that knockdown of nucleolin resulted
in inhibition of transcription by RNA polymerase I but not by
RNA polymerase II (Fig. 8B). Nevertheless, we cannot exclude
the possibility that nucleolin also contributes to transcription
by RNA polymerase II, as suggested by previous studies. For
example, nucleolin has been reported to alter the structure of
the chromatin in which human papillomavirus type 18 onco-
genes reside in cells derived from a cervical carcinoma (24) and
to interact in vitro with several proteins that regulate transcrip-
tion by RNA polymerase II (76, 88, 89). Global analyses of the
genes with which nucleolin associates in cells that are prolif-
erating or arrested (2) and of the effects of RNAi against
nucleolin are required to address this issue.
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